These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 381535)

  • 41. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunotherapy of chronic myelocytic leukemia.
    Sokal JE; Aungst CW; Grace JT
    Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
    [No Abstract]   [Full Text] [Related]  

  • 43. [Tumor immunologic aspects of lung cancer treatment].
    Nilsson B
    Lakartidningen; 1979 May; 76(20):1933-4. PubMed ID: 449470
    [No Abstract]   [Full Text] [Related]  

  • 44. [Current trends in immunotherapy of tumors of the lung].
    Crispano G; Toglia V; Tranchese D; Schettini R
    Arch Monaldi; 1983; 38(1-2):41-52. PubMed ID: 6675558
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives.
    Klein E; Holtermann OA; Papermaster B; Milgrom H; Rosner D; Klein L; Walker MJ; Zbar B
    Natl Cancer Inst Monogr; 1973 Dec; 39():229-42. PubMed ID: 4595323
    [No Abstract]   [Full Text] [Related]  

  • 46. [BCG immunotherapy as an adjuvant to surgery in lung cancer. An analysis of lymphocyte subsets of the peripheral blood using monoclonal antibodies].
    Miyazawa N; Tsuchiya R; Naruke T; Yoneyama T; Suemasu K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Jan; 23(1):56-61. PubMed ID: 3892115
    [No Abstract]   [Full Text] [Related]  

  • 47. An experimental model for immunotherapy of cancer.
    Zbar B; Ribi E; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
    [No Abstract]   [Full Text] [Related]  

  • 48. [BCG vaccine immunotherapy after radical operations for lung cancer].
    Repin IuM
    Vestn Khir Im I I Grek; 1992; 149(7-8):11-6. PubMed ID: 1341347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
    Peter HH; Deutschmann EM; Schultheis W; Deicher H
    Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of oil-attached BCG cell-wall skeleton and thymectomy on the incidence of lung cancer and amyloidosis induced by chemical carcinogens in rabbits.
    Hirao F; Nishikawa H; Yasaki S; Ogura T; Azuma I; Taniyama T; Yoshimoto T; Kishimoto S; Yamamura Y
    Gan; 1978 Aug; 69(4):453-9. PubMed ID: 101411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Introduction: animal models of immunotherapy of cancer.
    Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():1-2. PubMed ID: 4595318
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of anticancer therapy of lymphocyte cytotoxicity in lung cancer patients.
    Manabe H; Yasumoto K; Ohta M; Toyohira K; Nomoto K
    Gan; 1977 Aug; 68(4):477-82. PubMed ID: 357239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract]   [Full Text] [Related]  

  • 54. [Immunotherapy of lung cancer].
    Jassem J; Jassem E
    Pol Tyg Lek; 1982 Jun; 37(17):497-9. PubMed ID: 6292882
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunotherapy as related to lung cancer: a review.
    Hersh EM; Mavligit GM; Gutterman JU
    Semin Oncol; 1974 Sep; 1(3):273-8. PubMed ID: 4620434
    [No Abstract]   [Full Text] [Related]  

  • 56. Conference on the use of BCG in therapy of cancer. Summary remarks.
    Terry WD
    Natl Cancer Inst Monogr; 1973 Dec; 39():269-72. PubMed ID: 4595325
    [No Abstract]   [Full Text] [Related]  

  • 57. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rheusus monkey.
    Ribi E; Anacker RL; Barclay WR; Brehmer W; Harris SC; Leif WR; Simmons J
    J Infect Dis; 1971 May; 123(5):527-38. PubMed ID: 5000470
    [No Abstract]   [Full Text] [Related]  

  • 58. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
    McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
    Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunological status and surgery of cancer of the lung. Prognostic aspects and therapeutic prospects].
    Fegiz G; Di Paola M; Colizza S
    Minerva Chir; 1977 Jun; 32(11):677-82. PubMed ID: 329159
    [No Abstract]   [Full Text] [Related]  

  • 60. [Possible applications of living BCG and the BCG cell wall in immunotherapy].
    Canti GF; Franco P; Ricci L
    Boll Ist Sieroter Milan; 1983 May; 62(2):125-9. PubMed ID: 6626318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.